These compounds inhibit NEK2 activity by forming conserved hydrogen bonds, effectively impeding the proliferation of diverse tumour cells, including those in BrC, HCC and CRC.125, 126. The gene discussed is NEK2; the disease is hepatocellular carcinoma.